Medicinal composition for treating blood stasis and qi stagnation syndrome of primary liver cancer and preparation method thereof

A technology of primary liver cancer and composition, which is applied in the direction of drug combination, pharmaceutical formula, medical preparation of non-active ingredients, etc., can solve the problems of energy consumption, difficult filling operation, and affecting protein quality, so as to reduce labor intensity, Reduce the number of freezing and thawing, easy to store for a long time

Active Publication Date: 2011-11-02
BEIJING JIANSHENG PHARMA
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] 1. Only β-cyclodextrin is added to the raw medicine, which makes the raw medicine strong in moisture absorption, difficult to fill, and difficult to store for a long time;
[0004] 2. In the homogenization operation, "add the same amount of water" to make the material thicker, the ultrafiltration speed is slow, and the labor intensity is increased;
[0005] 3. The freezing temperature is -25°C, and the freezing time is prolonged, resulting in a large energy consumption;
[0006] 4. The melting temperatur

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for treating blood stasis and qi stagnation syndrome of primary liver cancer and preparation method thereof
  • Medicinal composition for treating blood stasis and qi stagnation syndrome of primary liver cancer and preparation method thereof
  • Medicinal composition for treating blood stasis and qi stagnation syndrome of primary liver cancer and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0043] Experimental example 1: research experiment on excipient change

[0044] 1. Test material:

[0045] Ultrafiltrate, β-cyclodextrin, medicinal starch, electronic balance (AUW-120D), electric heating constant temperature drying oven (WK891), electric heating constant temperature water bath (BS60), ultraviolet-visible spectrophotometer (PC-2400), micro Kjeldahl nitrogen analyzer, vacuum pump (SHB-III).

[0046] 2. Methods and Results

[0047] (1) Research on the proportion of excipients added:

[0048] Add β-cyclodextrin and starch to the ultrafiltrate in a certain proportion. Take 10 liters of ultrafiltrate and add β-cyclodextrin 0g, 20g, 40g, 80g, 120g, 172g respectively, freeze-dry and pulverize, add starch 172g, 152g, 132g, 92g, 52g, 0g in sequence, Dry to obtain each sample. Under the condition of 40% humidity (close to the ambient humidity controlled in the capsule filling production process), the initial sample mass and the mass of the sample exposed to the air ...

experiment example 2

[0063] Experimental example 2: process optimization research

[0064] 1. Research on the amount of water added to the homogenate

[0065] (1) Test materials: paste of fresh white snake, fresh viper and fresh gecko, low-speed centrifuge (SSN600), high-speed centrifuge (GQ-142), ultrafiltration machine (self-made), electronic balance (AUW -120D), electric constant temperature drying oven (WK891), electric constant temperature water bath (BS60), ultraviolet visible spectrophotometer (PC-2400), micro Kjeldahl nitrogen analyzer, vacuum pump (SHB-III).

[0066] (2) Method and results: under the production scale, take 50 kg of the paste and add 1, 2, 4 and 5 times the volume of water, homogenate, then freeze and thaw three times according to the original preparation method, filter, centrifuge, and ultrafilter , record the ultrafiltration speed, the total amount of filtrate, measure the concentration of ultrafiltrate, and calculate the total yield (see Table 3). Repeat the experimen...

Embodiment 1

[0119] Embodiment 1: Capsules

[0120] Fresh Shougong 40kg Fresh Money White Flower Snake 20kg Fresh Viper 20kg

[0121] β-cyclodextrin 1.07kg starch 3.52kg

[0122] Chop fresh gecko, fresh white snake and fresh viper into minced meat, grind into paste, add 4 times the volume of water to homogenate, freeze at -20°C for 24 hours, take it out, and thaw at 25°C. Filtrate, centrifuge the filtrate at 14,000 rpm, absorb the supernatant, ultra-filter, take the filtrate and add β-cyclodextrin inclusions, vacuum freeze-dry, crush into fine particles, add starch, mix well, and dry at low temperature to produce capsules. Take orally, take 3 times a day, take 4 capsules each time.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicinal composition for treating blood stasis and qi stagnation syndrome of primary liver cancer and a preparation method thereof. The preparation method is the improvement on a Jinlong capsule preparation process shown in the original pharmacopoeial standard WS3-158(Z-036)-2001Z. The improved raw material composition comprises fresh gecko, fresh little multibanded krait, fresh long-noded pit viper, beta-cyclodextrin and starch. The preparation process comprises the following steps of: chopping the fresh gecko, the fresh little multibanded krait and the fresh long-noded pit viper into comminuted meat, grinding into paste, adding water in an amount which is 4 times volume of the paste, performing homogenate, freezing for 24 hours at the temperature of -20 DEG C, taking out, thawing at the temperature of 25 DEG C, filtering, centrifuging filtrate at the rotation speed of 14,000rpm, sucking supernatant, ultrafiltering, taking filtrate, adding the beta-cyclodextrin and including, freeze-drying under vacuum, crushing to obtain fine particles, adding the starch, mixing uniformly, and drying at low temperature. The moisture absorption speed is low, the medicinal composition is easy to store for a long time, the ultrafiltration speed is high, the labor intensity is reduced, the production efficiency is high, energy sources can also be saved, and the quality of proteins is not affected.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition and a preparation method for treating primary liver cancer with blood stasis syndrome. Background technique [0002] The invention is an improvement based on the preparation process of the original Pharmacopoeia standard WS3-158(Z-036)-2001Z Jinlong capsule. There are following deficiencies in the original preparation process: [0003] 1. Only β-cyclodextrin is added to the raw medicine, which makes the raw medicine strong in moisture absorption, difficult to fill, and difficult to store for a long time; [0004] 2. In the homogenization operation, "add the same amount of water" to make the material thicker, the ultrafiltration speed is slow, and the labor intensity is increased; [0005] 3. The freezing temperature is -25°C, and the freezing time is prolonged, resulting in a large energy consumption; [0006] 4. The melting temperature is 37°C in a ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K35/58A61K47/48A61P35/00A61K35/56A61K35/583
Inventor 李建生
Owner BEIJING JIANSHENG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products